Advertisement

Search Results for "Address Change Of Catalent Pharma Solutions Inc"

13:45 EDT 21st May 2013 | BioPortfolio

Matching Channels

Solutions

Minimal Change Disease

Latin America

Latin America encompasses the Caribbean, South America and Central America. These countries are important players in the biotechnology industry, not only as consumers, but as contributors. The env...

Datamonitor - aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapidly evolving marketplace

The Datamonitor Group aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapi...

Laboratory

Labs are the hub of much of modern medicine, either in the hospital setting processing patients blood tests and other samples, in research institutions at many universities or in the headquarters of...

Matching News

New Issue-Catalent Pharma Solutions sells $350 mln notes

Sept 5 (Reuters) - Catalent Pharma Solutions Inc on Wednesday sold $350 million of senior notes in the 144a private placement market, said IFR, a Thomson Reuters service. The size of the deal wa...

Catalent, UMN Pharma collaborate on biosimilar development, production in Japan

Catalent Pharma Solutions, a Somerset, N.J.-based developer of solutions and drug delivery technology, has signed an agreement to provide UMN Pharma, a Japanese pharmaceutical company, a broad range o...

Catalent and UMN Pharma Announce Collaboration for Biosimilar Development and Production in Japan

Catalent Pharma Solutions and UMN Pharma Inc. today announced the signing of an agreement to provide UMN Pharma a broad range of biosimilar cell lines using Catalent’s proprietary GPEx ® techno...

Catalent and UMN Pharma collaborate for biosimilars development and production in Japan

Privately-held USA-based Catalent Pharma Solutions and Japanese drugmaker UMN Pharma (TYO Mothers: 4585) have signed an agreement to provide UMN Pharma a broad range of biosimilar cell lines using Cat...

UMN Pharma to produce biosimilars cell lines using Catalent GPEx technology

UMN Pharma has entered into a collaboration agreement with Catalent Pharma Solutions for the development and production of biosimilar cell lines.

UMN taps Catalent tech as it eyes biosimilar production, alliances for Asia

No sooner had the Japanese vaccines venture UMN Pharma listed on the Tokyo Stock Exchange than it struck its first post-IPO deal, linking up with Catalent Pharma Solutions for technology for the man...

Catalent and Bend Research partner to provide integrated solutions for oral controllled release technologies

Published date:  21/06/2012 Summary:  . Somerset, NJ and Bend, O...

Catalent Pharma launches Catalent Applied Drug Delivery Institute

Catalent Pharma Solutions, a developer of solutions and advanced drug delivery technologies, has launched its Catalent Applied Drug Delivery Institute.

Matching PubMed Articles

Comment about the article "Psychopharmaceuticals and diabetes" of Ress C, Tschoner A, Kaser S, and Ebenbichler CF in Wiener Medizinische Wochenschrift 2011; 161/21-22: 531-42.

A fluorescence reagent for the highly selective recognition and separation of lead ion (II) from aqueous solutions.

A new fluorescence reagent, N,N-bi[4(1-pyrene)-butyroyl]-lysine (1) was synthesized. The new fluorescence sensor showed high sensitivity (detection limit up to 20.7μgL(-1)) and specific selectivity f...

Discovery of new chemotype dipeptidyl peptidase IV inhibitors having (R)-3-amino-3-methyl piperidine as a pharmacophore.

Structures containing the (R)-3-amino-3-methyl piperidine unit as a new pharmacophore moiety have been shown to possess moderate inhibitory activity for DPP-4 with good pharmacokinetics profile. One o...

Structure of iron ions in some acetone based electrolytes.

X-ray absorption, Mössbauer, and Raman spectroscopy were combined to determine the local environment of iron ions in acetone based solutions of FeCl2. It is shown that part of the Fe(II) ions change...

The effect of soft contact lens care products on lens modulus.

PURPOSE: To examine the relative changes in modulus of nine soft contact lens materials when exposed to three lens care solutions. METHOD: Measurements of elastic modulus were made using an Instron 33...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement